v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current Assets:    
Cash and cash equivalents $ 1,511,188 $ 547,890
Investments held in marketable securities 1,441,734 10,184,701
Accounts receivable 15,500 188,400
Prepaid expenses and other current assets 168,440 223,230
Total Current Assets 3,136,862 11,144,221
Deferred offering costs 49,808 148,697
Property and equipment, net 358,767 362,936
Intangible assets, net 534,198 623,945
Total Assets 4,079,635 12,279,799
Current Liabilities:    
Accounts payable 1,341,495 483,070
Accrued expenses and other current liabilities 982,047 744,485
Warrant liabilities 1,399,349 2,520,851
Total Current Liabilities 3,722,891 3,748,406
Commitments and contingencies
Stockholders’ Equity:    
Common stock, $0.0001 par value; 75,000,000 shares authorized; 8,876,242 and 6,919,919 shares issued and outstanding at December 31, 2025 and 2024, respectively 887 692
Additional paid-in capital 170,262,565 164,195,434
Accumulated deficit (169,920,690) (155,678,715)
Total Stockholders’ Equity 356,744 8,531,393
Total Liabilities and Stockholders’ Equity 4,079,635 12,279,799
Series B Convertible Preferred Stock [Member]    
Stockholders’ Equity:    
StatementClassOfStockAxis $ 13,982 $ 13,982

Source

10-K XBRL Zip